Carmine Therapeutics announced today that it has signed a research collaboration agreement with Takeda Pharmaceutical to discover, develop and commercialize transformative non-viral gene therapies for two rare disease targets using Carmine's...
Read More »Carmine Therapeutics launches – a company pioneering red blood cell (RBC)-derived extracellular vesicle (EV)-based gene therapies
Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of Professors Minh Leand Jiahai Shi at the City University of Hong Kong. Carmine Therapeutics plans to ...
Read More »